Moves to re-schedule over-the-counter codeine products to prescription-only status have been put on hold. The decision on whether to reschedule drugs that contain codeine combinations has been deferred until June 2016 to allow the TGA to evaluate the large number of submissions. The TGA received 127 submissions, of which 113 were in opposition to the proposal to ...
Already a member?
Enter your email to keep reading.